The King’s Fund welcomes two new Trustees

This content relates to the following topics:

The King’s Fund is delighted to welcome Thomas Hughes-Hallett and Sir Jonathan Michael as new members of the Fund’s Board of Trustees.

Thomas Hughes-Hallett has been the Chief Executive of Marie Curie Cancer Care since 2000, and has held a number of other senior roles including Chairman of the Department of Health’s End of Life Care Strategy Implementation Advisory Board and Board Member of the National Cancer Strategy.

Sir Jonathan Michael is Chief Executive of Oxford University Hospitals NHS Trust, and his previous roles include Managing Director of BT Health, Chief Executive of Guys and St Thomas’s Hospitals NHS Foundation Trust and Chief Executive of University Hospitals Birmingham NHS Trust. Sir Jonathan, who began his career as a consultant physician, has also acted as Chairman of the Board for NHS Innovations London and the NHS Foundation Trust Network, and was knighted for services to the NHS in 2005.

Commenting on the appointment of Thomas Hughes-Hallett and Sir Jonathan Michael to the King’s Fund’s Board of Trustees, Sir Christopher Kelly, Chairman of The King’s Fund, said:

‘I am delighted to welcome two such distinguished and respected members to our Board of Trustees. Both Thomas Hughes-Hallett and Sir Jonathan Michael have made a huge contribution to health care throughout their careers, and will use their knowledge to help strengthen our top team.

‘Our Board of Trustees is responsible for the strategic direction of The King’s Fund, and I know our new members will ensure that The King’s Fund continues to make a significant contribution to the future of health and social care in England.’

Notes to editors

The Board of Trustees are appointed for a three-year renewable term, and meet seven times a year. Their role is to agree the organisation's overall strategic direction, in line with its charitable objectives, and to scrutinise management functions delegated to the Senior Management Team.

For further information, or to request an interview, please contact the Press and Public Affairs team on 020 7307 2632 (if calling out of hours, please ring 07584 146 035).